首页 > 最新文献

Klinicheskaia meditsina最新文献

英文 中文
[TRENDS IN DEVELOPMENT OF GI-SAFE ANTI-INFLAMMATORY DRUGS]. [gi安全抗炎药的发展趋势]。
Pub Date : 2017-01-01
O N Sulaieva, J L Wallace

Despite the introduction of anti-inflammatory drugs that selectively inhibit cyclo-oxygenase-2 (COX-2), and potent inhibitors of gastric acid secretion, the gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs) remain a significant clinical problem. Combined use of antisecretory drugs and COX-2 inhibitors is helpful to limit the damage in the proximal gastrointestinal tract (stomach and duodenum), but it increases the risk of injury of small intestine and colon. It was proven that proton pump inhibitors and H2 receptor antagonists significantly worsen NSAID-induced small intestinal damage and microbiota balance. Nowadays, there is no proven effective preventative or curative treatment for NSAID-induced enteropathy. The new strategy of gastrointestinal protection is based on the discovery of endogenous cytoprotective molecules such as hydrogen sulfide (H₂S). H2S is a gaseous mediator that produces strong cytoprotective and antioxidant effect on the gastrointestinal tract. The role of H₂S in promoting mucosal integrity, healing of tissue injury and resolution of inflammation has been well documented. In addition, H₂S stimulates productions of other cytoprotective molecules including prostaglandins, carbon monoxide and nitric oxide. Nowadays, the new generation of H₂S-releasing non-steroidal anti-inflammatory drugs is developed and tested in clinical trials. H₂S-NSAIDs possess enhanced anti-inflammatory activity and high gastrointestinal safety.

尽管引入了选择性抑制环氧化酶-2 (COX-2)和强效胃酸分泌抑制剂的抗炎药物,但非甾体抗炎药(NSAIDs)的胃肠道不良反应仍然是一个重要的临床问题。联合使用抗分泌药物和COX-2抑制剂有助于限制近端胃肠道(胃和十二指肠)的损伤,但增加了小肠和结肠损伤的风险。事实证明,质子泵抑制剂和H2受体拮抗剂显著加重nsaid诱导的小肠损伤和微生物群平衡。目前,对于非甾体抗炎药引起的肠病,尚无有效的预防或治疗方法。新的胃肠保护策略是基于发现内源性细胞保护分子,如硫化氢(H₂S)。H2S是一种气体介质,对胃肠道具有很强的细胞保护和抗氧化作用。h2s在促进粘膜完整性、组织损伤愈合和炎症消退中的作用已被充分证实。此外,h2s还会刺激前列腺素、一氧化碳和一氧化氮等其他细胞保护分子的产生。目前,新一代释放H₂s的非甾体抗炎药正在开发和临床试验中。H₂S-NSAIDs具有较强的抗炎活性和较高的胃肠道安全性。
{"title":"[TRENDS IN DEVELOPMENT OF GI-SAFE ANTI-INFLAMMATORY DRUGS].","authors":"O N Sulaieva,&nbsp;J L Wallace","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Despite the introduction of anti-inflammatory drugs that selectively inhibit cyclo-oxygenase-2 (COX-2), and potent inhibitors of gastric acid secretion, the gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs) remain a significant clinical problem. Combined use of antisecretory drugs and COX-2 inhibitors is helpful to limit the damage in the proximal gastrointestinal tract (stomach and duodenum), but it increases the risk of injury of small intestine and colon. It was proven that proton pump inhibitors and H2 receptor antagonists significantly worsen NSAID-induced small intestinal damage and microbiota balance. Nowadays, there is no proven effective preventative or curative treatment for NSAID-induced enteropathy. The new strategy of gastrointestinal protection is based on the discovery of endogenous cytoprotective molecules such as hydrogen sulfide (H₂S). H2S is a gaseous mediator that produces strong cytoprotective and antioxidant effect on the gastrointestinal tract. The role of H₂S in promoting mucosal integrity, healing of tissue injury and resolution of inflammation has been well documented. In addition, H₂S stimulates productions of other cytoprotective molecules including prostaglandins, carbon monoxide and nitric oxide. Nowadays, the new generation of H₂S-releasing non-steroidal anti-inflammatory drugs is developed and tested in clinical trials. H₂S-NSAIDs possess enhanced anti-inflammatory activity and high gastrointestinal safety.</p>","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"95 3","pages":"222-7"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36571011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[PEMPHIGUS ACANTHOLYTICUS PARANEOPLASTIC: LITERATURE REVIEW AND CASE REPORT]. 【副肿瘤性棘溶性天疱疮:文献回顾及病例报告】。
Pub Date : 2017-01-01
M A Ufimtseva, Ju M Bochkarev, E P Gurkovskaya, K I Nikolaeva, O D Lesnaya

The article describes the clinical observation of a rare severe dermatosis, paraneoplastic acantholyticus pemphigus, associated with colon cancer with reference to pathogenesis, clinical variations and difficulties of diagnostics of this condition.

本文报道了一种罕见的伴有结肠癌的严重皮肤病——副肿瘤性棘漏性天疱疮的临床观察,并对该病的发病机制、临床变化及诊断难点进行了阐述。
{"title":"[PEMPHIGUS ACANTHOLYTICUS PARANEOPLASTIC: LITERATURE REVIEW AND CASE REPORT].","authors":"M A Ufimtseva,&nbsp;Ju M Bochkarev,&nbsp;E P Gurkovskaya,&nbsp;K I Nikolaeva,&nbsp;O D Lesnaya","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The article describes the clinical observation of a rare severe dermatosis, paraneoplastic acantholyticus pemphigus, associated with colon cancer with reference to pathogenesis, clinical variations and difficulties of diagnostics of this condition.</p>","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"95 3","pages":"278-80"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36571808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[CARDIOVASCULAR DISEASES: EVALUATION OF PERSISTING DISORDERS IN THE BLOOD CIRCULATION SYSTEM AND DISABILITY, CRITERIA FOR SEVERITY OF INVALIDISM]. [心血管疾病:血液循环系统持续紊乱和残疾的评估,残疾严重程度的标准]。
Pub Date : 2017-01-01
M A Shurgaya

A most important indicator of population health, its social and economic wellbeing is premature disability. 10.3 mln people had to retire from their jobs due to disability during the ten-year period from 2005 to 2014. The number of elderly subjects among them was twice that of the younger ones, with the leading cause of disability being blood circulation disorders (61,9%). At the same time, the fraction of old subjects in the group of invalids suffering from coronary heart disease and idiopathic hypertension accounted for only 58,9% and 40,9% respectively. The quantitative evaluation of persistent dysfunction of the cardiovascular system related to circulatory disturbances included in ICD class IX and to those referred to other classes is based mainly on an assessment of the following clinical and functional manifestations: pain syndrome (cardialgia or angina); hypertensive syndrome; pulmonary hypertension; arrhythmia; syncope. Other aspects of pathological process are taken into consideration, such as its form and severity, presence and frequency of exacerbations, magnitude, involvement of target organs, complications. The gerontological slant of disabling cardiovascular pathology accounts for its social significance (idiopathic hypertension, coronary heart disease, chronic heart failure) which requires the adequate solution of the problem of healthcare provisions taking account of the current demographic situation and increased life expectancy within the older population suffering from a number of chronic diseases.

人口健康及其社会和经济福利的一个最重要指标是过早残疾。从2005年到2014年的十年间,有1030万人因残疾而不得不退休。其中老年人的数量是年轻人的2倍,导致残疾的主要原因是血液循环障碍(61.9%)。同时,老年受试者在残废冠心病和特发性高血压组中所占比例分别仅为58.9%和40.9%。ICD第九类和其他分类中与循环障碍相关的心血管系统持续功能障碍的定量评估主要基于以下临床和功能表现的评估:疼痛综合征(心绞痛或心绞痛);高血压综合征;肺动脉高压;心律失常;晕厥。考虑到病理过程的其他方面,如其形式和严重程度,恶化的存在和频率,程度,累及靶器官,并发症。致残心血管疾病的老年学倾向说明了其社会意义(特发性高血压、冠心病、慢性心力衰竭),这要求充分解决保健服务问题,同时考虑到目前的人口状况和患有一些慢性疾病的老年人口的预期寿命增加。
{"title":"[CARDIOVASCULAR DISEASES: EVALUATION OF PERSISTING DISORDERS IN THE BLOOD CIRCULATION SYSTEM AND DISABILITY, CRITERIA FOR SEVERITY OF INVALIDISM].","authors":"M A Shurgaya","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A most important indicator of population health, its social and economic wellbeing is premature disability. 10.3 mln people had to retire from their jobs due to disability during the ten-year period from 2005 to 2014. The number of elderly subjects among them was twice that of the younger ones, with the leading cause of disability being blood circulation disorders (61,9%). At the same time, the fraction of old subjects in the group of invalids suffering from coronary heart disease and idiopathic hypertension accounted for only 58,9% and 40,9% respectively. The quantitative evaluation of persistent dysfunction of the cardiovascular system related to circulatory disturbances included in ICD class IX and to those referred to other classes is based mainly on an assessment of the following clinical and functional manifestations: pain syndrome (cardialgia or angina); hypertensive syndrome; pulmonary hypertension; arrhythmia; syncope. Other aspects of pathological process are taken into consideration, such as its form and severity, presence and frequency of exacerbations, magnitude, involvement of target organs, complications. The gerontological slant of disabling cardiovascular pathology accounts for its social significance (idiopathic hypertension, coronary heart disease, chronic heart failure) which requires the adequate solution of the problem of healthcare provisions taking account of the current demographic situation and increased life expectancy within the older population suffering from a number of chronic diseases.</p>","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"95 2","pages":"158-62"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36579051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[DESIALATED LOW DENSITY LIPOPROTEINS IN HUMAN BLOOD]. [人体血液中绝望的低密度脂蛋白]。
Pub Date : 2017-01-01
A I Ryzhkova, V P Karagodin, V N Sukhorukov, M A Sazonova, A N Orekhov

The present article is a review of literature on circulating low-density lipoproteins (LDLP) which can induce accumulation of lipids (mainly, cholesterol), in a SMA(+) cell culture of normal human aortic intima. An attempt was undertaken to resolve the paradox of the absence of both native LDLP influence on intracellular lipid accumulation and modifications of in vitro obtained LDLP in the blood-vascular system. It was showed that atherogenic LDLPs are characterized by a number of changes in carbon, protein and lipid components which can be regarded as multiple modifications of LDLP taking place in human blood plasma. Multiply modified circulating LDLP possess of capacity to interact with various cell membrane receptors differing from B and E receptor, and with proteoglycans. Marked absorption of desiliated LDLPs by the cells simultaneous with a decrease in the degradation of apolipoproteins and cholesterol esters as well as induction of peresterification of free cholesterol leads to intracellular accumulation of esterified cholesterol. Formation of large LDLP-containing complexes especially circulating low-density lipoproteins can stimulate accumulation of lipids by smooth muscle cells of intima. Desiliated LDLPs stimulated cell proliferation and connective tissue matrix synthesis despite cholesterol ester accumulation. In conclusion, the authors of this article found and characterized natural multiply modified LDLPs that can be responsible for the symptoms of atherosclerosis at the cellular level.

本文综述了在正常人主动脉内膜SMA(+)细胞培养中循环低密度脂蛋白(LDLP)可诱导脂质(主要是胆固醇)积累的相关文献。本文试图解决天然低密度脂蛋白对细胞内脂质积累的影响和体外获得的低密度脂蛋白在血管系统中的修饰缺失的悖论。研究表明,致动脉粥样硬化的低密度脂蛋白具有碳、蛋白质和脂质成分的许多变化的特征,这可以被认为是发生在人血浆中的低密度脂蛋白的多重修饰。多重修饰的循环LDLP具有与不同于B和E受体的多种细胞膜受体和蛋白聚糖相互作用的能力。细胞对脱脂低密度脂蛋白的显著吸收,同时载脂蛋白和胆固醇酯降解的减少,以及诱导游离胆固醇的过酯化,导致细胞内酯化胆固醇的积累。大的含低密度脂蛋白复合物的形成,特别是循环低密度脂蛋白,可以刺激内膜平滑肌细胞的脂质积累。脱脂的低密度脂蛋白刺激细胞增殖和结缔组织基质合成,尽管胆固醇酯积累。总之,本文作者发现并描述了在细胞水平上可能导致动脉粥样硬化症状的天然多重修饰的低密度脂蛋白。
{"title":"[DESIALATED LOW DENSITY LIPOPROTEINS IN HUMAN BLOOD].","authors":"A I Ryzhkova,&nbsp;V P Karagodin,&nbsp;V N Sukhorukov,&nbsp;M A Sazonova,&nbsp;A N Orekhov","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The present article is a review of literature on circulating low-density lipoproteins (LDLP) which can induce accumulation of lipids (mainly, cholesterol), in a SMA(+) cell culture of normal human aortic intima. An attempt was undertaken to resolve the paradox of the absence of both native LDLP influence on intracellular lipid accumulation and modifications of in vitro obtained LDLP in the blood-vascular system. It was showed that atherogenic LDLPs are characterized by a number of changes in carbon, protein and lipid components which can be regarded as multiple modifications of LDLP taking place in human blood plasma. Multiply modified circulating LDLP possess of capacity to interact with various cell membrane receptors differing from B and E receptor, and with proteoglycans. Marked absorption of desiliated LDLPs by the cells simultaneous with a decrease in the degradation of apolipoproteins and cholesterol esters as well as induction of peresterification of free cholesterol leads to intracellular accumulation of esterified cholesterol. Formation of large LDLP-containing complexes especially circulating low-density lipoproteins can stimulate accumulation of lipids by smooth muscle cells of intima. Desiliated LDLPs stimulated cell proliferation and connective tissue matrix synthesis despite cholesterol ester accumulation. In conclusion, the authors of this article found and characterized natural multiply modified LDLPs that can be responsible for the symptoms of atherosclerosis at the cellular level.</p>","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"95 3","pages":"216-21"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36571009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[PITUITARY ADENOMA APOPLEXY]. [垂体腺瘤中风]。
Pub Date : 2017-01-01
I V Tereshchenko

We present 3 cases of pituitary adenoma apoplexy in young women (one microadenoma and two macroadenomas). The possible risk factors, clinical presentation and outcome of pituitary apoplexy are discussed. Diagnostic errors as regards pituitary adenoma apoplexy are analyzed.

我们报告3例年轻女性垂体腺瘤中风(1例微腺瘤和2例大腺瘤)。讨论垂体卒中的可能危险因素、临床表现及预后。分析垂体腺瘤中风的诊断错误。
{"title":"[PITUITARY ADENOMA APOPLEXY].","authors":"I V Tereshchenko","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We present 3 cases of pituitary adenoma apoplexy in young women (one microadenoma and two macroadenomas). The possible risk factors, clinical presentation and outcome of pituitary apoplexy are discussed. Diagnostic errors as regards pituitary adenoma apoplexy are analyzed.</p>","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"95 2","pages":"177-80"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36579055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A critical incident during marathon competition as a result of metabolic decompensation]. [马拉松比赛中因代谢失代偿引起的严重事件]。
Pub Date : 2017-01-01 DOI: 10.18821/0023-2149-2017-95-1-85-89
Y. Orlov, N. Govorova, A. Glushchenko, E. Efremov, Yu B Vasilenko
A case of polyorganic insufficiency syndrome associated with coma, convulsive disorder, acute hepato-renal and respiratory dysfunction, hypovolemic shock, and hyperthermal syndrome in a 46 year-old participant ofa marathon competition is reported. The clinical picture was dominated by acute hepatic insufficiency treated with remaxol to activate substrate phosphorylation under effect of exogenous succinate for slowing down the development of energy deficit in mitochondria under condition of oxygen deficit. This case can be regarded as a variant of correction of mitochondrial dysfunction with the use of a mitochondria-targeted medication such as succinate-containing remaxol. This medication reduced AST and ALT activities and utilization of endogenous enzymes for succinate synthesis from alanine and aspartate under hypoxic conditions. Prescription of remaxol as a form of direct substitution therapy was dictated by pathogenetic considerations.
本文报告了一例46岁马拉松比赛参与者的多器官功能不全综合征,并伴有昏迷、惊厥障碍、急性肝肾和呼吸功能障碍、低血容量性休克和高热综合征。临床表现以急性肝功能不全为主,在外源性琥珀酸盐的作用下,用利马索激活底物磷酸化,以减缓缺氧条件下线粒体能量缺陷的发展。这种情况可以被视为线粒体功能障碍的一种变体,使用线粒体靶向药物,如含琥珀酸的利美索。该药物降低了缺氧条件下丙氨酸和天冬氨酸合成琥珀酸的内源性酶的利用率和AST和ALT活性。处方雷马索作为一种形式的直接替代治疗是由致病因素决定的。
{"title":"[A critical incident during marathon competition as a result of metabolic decompensation].","authors":"Y. Orlov, N. Govorova, A. Glushchenko, E. Efremov, Yu B Vasilenko","doi":"10.18821/0023-2149-2017-95-1-85-89","DOIUrl":"https://doi.org/10.18821/0023-2149-2017-95-1-85-89","url":null,"abstract":"A case of polyorganic insufficiency syndrome associated with coma, convulsive disorder, acute hepato-renal and respiratory dysfunction, hypovolemic shock, and hyperthermal syndrome in a 46 year-old participant ofa marathon competition is reported. The clinical picture was dominated by acute hepatic insufficiency treated with remaxol to activate substrate phosphorylation under effect of exogenous succinate for slowing down the development of energy deficit in mitochondria under condition of oxygen deficit. This case can be regarded as a variant of correction of mitochondrial dysfunction with the use of a mitochondria-targeted medication such as succinate-containing remaxol. This medication reduced AST and ALT activities and utilization of endogenous enzymes for succinate synthesis from alanine and aspartate under hypoxic conditions. Prescription of remaxol as a form of direct substitution therapy was dictated by pathogenetic considerations.","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"14 1","pages":"85-9"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86775717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[PERSONALIZED MEDICINE IN INTERNAL MEDICINE]. [内科个体化医疗]。
Pub Date : 2017-01-01 DOI: 10.18821/0023-2149-2017-95-3-197-200
V. Kukes, V. Marinin, Yu. V. Olefir, G. Ramenskaya, N. Lazareva, V. Smirnov, M. Zhuravleva, A. Prokofiev, E. Shih, A. Zhestovskaia, N. Rumyantsev, D. Mandich, O. Goroshko
Personalized medicine - a new direction in medicine, which is based on the study of various biomarkers and the use of new methods of molecular analysis (primarily evaluating the activity of isoenzymes of cytochrome P450), allowing individualized approach to the selection of both the drugs and the selection of the dosing regimen for the purpose of maximize the effectiveness and safety of pharmacotherapy. This personalized medicine is to change the development and use of preventive and curative interventions. Genetic polymorphism isozymes of cytochrome P450 may determine the individual activity of a particular isozyme, and thus, to predict the clinical effectiveness, and in some cases, the risk of adverse reactions. The article is an example of the use of information on the activity of cytochrome P450 in clinical practice in matters of diagnosis, treatment and prevention of diseases. The scheme of the five best-known activity of isoenzymes of cytochrome P450 is shown.
个体化医学——医学的一个新方向,它基于对各种生物标志物的研究和使用新的分子分析方法(主要是评估细胞色素P450同工酶的活性),允许个体化方法来选择药物和选择给药方案,以最大限度地提高药物治疗的有效性和安全性。这种个性化医疗将改变预防和治疗干预措施的发展和使用。细胞色素P450基因多态性同工酶可以决定特定同工酶的个体活性,从而预测临床疗效,在某些情况下,还可以预测不良反应的风险。这篇文章是在诊断、治疗和预防疾病的临床实践中使用细胞色素P450活性信息的一个例子。给出了细胞色素P450同工酶的5种最著名的活性谱图。
{"title":"[PERSONALIZED MEDICINE IN INTERNAL MEDICINE].","authors":"V. Kukes, V. Marinin, Yu. V. Olefir, G. Ramenskaya, N. Lazareva, V. Smirnov, M. Zhuravleva, A. Prokofiev, E. Shih, A. Zhestovskaia, N. Rumyantsev, D. Mandich, O. Goroshko","doi":"10.18821/0023-2149-2017-95-3-197-200","DOIUrl":"https://doi.org/10.18821/0023-2149-2017-95-3-197-200","url":null,"abstract":"Personalized medicine - a new direction in medicine, which is based on the study of various biomarkers and the use of new methods of molecular analysis (primarily evaluating the activity of isoenzymes of cytochrome P450), allowing individualized approach to the selection of both the drugs and the selection of the dosing regimen for the purpose of maximize the effectiveness and safety of pharmacotherapy. This personalized medicine is to change the development and use of preventive and curative interventions. Genetic polymorphism isozymes of cytochrome P450 may determine the individual activity of a particular isozyme, and thus, to predict the clinical effectiveness, and in some cases, the risk of adverse reactions. The article is an example of the use of information on the activity of cytochrome P450 in clinical practice in matters of diagnosis, treatment and prevention of diseases. The scheme of the five best-known activity of isoenzymes of cytochrome P450 is shown.","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"53 1","pages":"197-200"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83892959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[INFLAMMATION AND HEMOCOAGULATION]. [炎症和血液凝固]。
Pub Date : 2017-01-01 DOI: 10.18821/0023-2149-2017-95-2-101-105
I. N. Bokarev
Problems of inflammation are extensively studied all over the world. Its mechanisms are known to involve hundreds of factors. The blood coagulation system is a major component of each living organism. This article was designed to analyze the relationship between inflammation and hemocoagulation and discuss definition of the term “low-grade inflammation” with reference to the blood coagulation system.
全世界都在广泛研究炎症问题。其机制涉及数百种因素。凝血系统是每个生物体的主要组成部分。本文旨在分析炎症与凝血的关系,并结合凝血系统探讨“低度炎症”的定义。
{"title":"[INFLAMMATION AND HEMOCOAGULATION].","authors":"I. N. Bokarev","doi":"10.18821/0023-2149-2017-95-2-101-105","DOIUrl":"https://doi.org/10.18821/0023-2149-2017-95-2-101-105","url":null,"abstract":"Problems of inflammation are extensively studied all over the world. Its mechanisms are known to involve hundreds of factors. The blood coagulation system is a major component of each living organism. This article was designed to analyze the relationship between inflammation and hemocoagulation and discuss definition of the term “low-grade inflammation” with reference to the blood coagulation system.","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"21 1","pages":"101-5"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78799236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Dynamics of clinical, X-ray and functional data during treatment of patients with sarcoidosis]. [结节病患者治疗过程中临床、x线和功能资料的动态变化]。
Pub Date : 2017-01-01
I Yu Vizel, A A Vizel

Aim: To analyze the literature data and the results of original studies on the respiratory function in patients with sarcoidosis.

Material and methods: The study included 1199 patients with sarcoidosis (67.8% women and 32.2% of males, median age 43 years). The first X-ray stage was documented in 34.8% of patients , stage II in 57.0%, stage III in 6.1%, stage IV in 1.3%, stage 0 in 0.7%. One patient (0.1%) had pleural sarcoidosis. Loefgren syndrome was diagnosed in 20% of the patients. In 658 patients (54.9%) the diagnosis was confirmed by biopsy studies.

Results: The patients with sarcoidosis exhibited significant correlation between radiographic and spirometric characteristics. In those with Loefgren syndrome, all breathing parameters were much better than in the remaining ones. Changes of spirometry parameters were more pronounced in smokers and in patients with concomitant lung diseases. However, the lung function remained impaired after adjustment for these factors, and 9,7% of the cases positively responded to the administration of a short-acting bronchodilator. Х-ray examination and spirometry are independent methods for the evaluation of the health status of patients with sarcoidosis and their results do not always correlate with each other after different treatment regimens. Changes in Х-ray image and lung vital capacity were consistent in patients treated with prednisone, methotrexate and pentoxifylline, but not in the cases treated with vitamin E and in the absence of treatment. Spirometry with simultaneous X-ray examination is recommended for all patients with intrathoracic sarcoidosis.

Conclusion: Forced vital capacity of lungs (FVC) is an independent criterion for evaluating the condition of patients with sarcoidosis and the effectiveness of the treatment.

目的:对结节病患者呼吸功能的文献资料和原创性研究结果进行分析。材料和方法:研究纳入1199例结节病患者(67.8%为女性,32.2%为男性,中位年龄43岁)。第一次x线分期为34.8%,II期为57.0%,III期为6.1%,IV期为1.3%,0期为0.7%。1例(0.1%)有胸膜结节病。20%的患者被诊断为洛夫格伦综合征。658例(54.9%)患者的诊断经活检证实。结果:结节病患者的影像学特征与肺量学特征有显著相关性。在患有洛夫格伦综合征的患者中,所有呼吸参数都比其他患者好得多。肺量测定参数的变化在吸烟者和合并肺部疾病的患者中更为明显。然而,在调整这些因素后,肺功能仍然受损,9.7%的病例对短效支气管扩张剂的使用有积极反应。Х-ray检查和肺活量测定是评价结节病患者健康状况的独立方法,在不同治疗方案后,两者的结果并不总是相互关联的。在接受强的松、甲氨蝶呤和己酮茶碱治疗的患者中,Х-ray图像和肺活量的变化是一致的,但在接受维生素E治疗和未接受治疗的患者中则不是这样。所有胸内结节病患者均建议肺量测定并同时进行x线检查。结论:肺用力肺活量(FVC)是评价结节病患者病情及治疗效果的独立标准。
{"title":"[Dynamics of clinical, X-ray and functional data during treatment of patients with sarcoidosis].","authors":"I Yu Vizel,&nbsp;A A Vizel","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>To analyze the literature data and the results of original studies on the respiratory function in patients with sarcoidosis.</p><p><strong>Material and methods: </strong>The study included 1199 patients with sarcoidosis (67.8% women and 32.2% of males, median age 43 years). The first X-ray stage was documented in 34.8% of patients , stage II in 57.0%, stage III in 6.1%, stage IV in 1.3%, stage 0 in 0.7%. One patient (0.1%) had pleural sarcoidosis. Loefgren syndrome was diagnosed in 20% of the patients. In 658 patients (54.9%) the diagnosis was confirmed by biopsy studies.</p><p><strong>Results: </strong>The patients with sarcoidosis exhibited significant correlation between radiographic and spirometric characteristics. In those with Loefgren syndrome, all breathing parameters were much better than in the remaining ones. Changes of spirometry parameters were more pronounced in smokers and in patients with concomitant lung diseases. However, the lung function remained impaired after adjustment for these factors, and 9,7% of the cases positively responded to the administration of a short-acting bronchodilator. Х-ray examination and spirometry are independent methods for the evaluation of the health status of patients with sarcoidosis and their results do not always correlate with each other after different treatment regimens. Changes in Х-ray image and lung vital capacity were consistent in patients treated with prednisone, methotrexate and pentoxifylline, but not in the cases treated with vitamin E and in the absence of treatment. Spirometry with simultaneous X-ray examination is recommended for all patients with intrathoracic sarcoidosis.</p><p><strong>Conclusion: </strong>Forced vital capacity of lungs (FVC) is an independent criterion for evaluating the condition of patients with sarcoidosis and the effectiveness of the treatment.</p>","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"95 1","pages":"60-5"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36557489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[MELATONIN: THE POSSIBILITY TO ANALYSE THE MARKER OF AGE-RELATED PATHOLOGY IN THE BUCCAL EPITHELIUM AND URINE]. [褪黑素:分析口腔上皮和尿液中年龄相关病理标志物的可能性]。
Pub Date : 2017-01-01
S S Konovalov, V O Polyakova, A O Drobintseva, I M Kvetnoy, T V Kvetnaia, N S Linkova

Extrapineal and pineal melatonin is the marker of the aging rate of organism making it possible to characterize functional condition of the neuro-immuno-endocrine system. In this article we have used the new method for non-invasive diagnostics of melatonin expression in buccal epithelium and determination of the main melatonin metabolite 6-hydroxymelatonin sulfate (6-HMS) in urine of elderly people. Normal, impaired and enhanced melatonin expression was documented in 20.5%, 43.2% and 36.30% of the patients respectively. Such comprehensive melatonin and 6-COMT studies can be recommended for elderly patients with oncological, neurodegenerative, cardiovascular diseases, and ageing macular dystrophy. Moreover, melatonin expression analysis in buccal cells can be used for integral investigation of biorhythms in elderly people.

松果体褪黑素是生物体衰老速度的标志,使表征神经-免疫-内分泌系统的功能状况成为可能。本文应用无创诊断方法检测老年人口腔上皮中褪黑素的表达及尿中褪黑素主要代谢物硫酸6-羟基褪黑素(6-HMS)的含量。褪黑素表达正常、受损和增强的比例分别为20.5%、43.2%和36.30%。此类综合褪黑素和6-COMT研究可推荐用于老年肿瘤、神经退行性疾病、心血管疾病和老年性黄斑营养不良患者。此外,口腔细胞中褪黑素的表达分析可用于老年人生物节律的整体研究。
{"title":"[MELATONIN: THE POSSIBILITY TO ANALYSE THE MARKER OF AGE-RELATED PATHOLOGY IN THE BUCCAL EPITHELIUM AND URINE].","authors":"S S Konovalov,&nbsp;V O Polyakova,&nbsp;A O Drobintseva,&nbsp;I M Kvetnoy,&nbsp;T V Kvetnaia,&nbsp;N S Linkova","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Extrapineal and pineal melatonin is the marker of the aging rate of organism making it possible to characterize functional condition of the neuro-immuno-endocrine system. In this article we have used the new method for non-invasive diagnostics of melatonin expression in buccal epithelium and determination of the main melatonin metabolite 6-hydroxymelatonin sulfate (6-HMS) in urine of elderly people. Normal, impaired and enhanced melatonin expression was documented in 20.5%, 43.2% and 36.30% of the patients respectively. Such comprehensive melatonin and 6-COMT studies can be recommended for elderly patients with oncological, neurodegenerative, cardiovascular diseases, and ageing macular dystrophy. Moreover, melatonin expression analysis in buccal cells can be used for integral investigation of biorhythms in elderly people.</p>","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"95 2","pages":"136-9"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36560663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Klinicheskaia meditsina
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1